SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Finn Maria)
 

Search: WFRF:(Finn Maria) > (2010-2014) > Selection of an opt...

Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re.

Altai, Mohamed (author)
Uppsala universitet,Enheten för biomedicinsk strålningsvetenskap,Tolmachev
Honarvar, Hadis (author)
Uppsala universitet,Enheten för biomedicinsk strålningsvetenskap,Tolmachev
Wållberg, Helena (author)
KTH,Proteinteknologi
show more...
Strand, Joanna (author)
Uppsala universitet,Enheten för biomedicinsk strålningsvetenskap,Tolmachev
Varasteh, Zohreh (author)
Uppsala universitet,Plattformen för preklinisk PET,Orlova
Rosestedt, Maria (author)
Uppsala universitet,Plattformen för preklinisk PET,Orlova
Orlova, Anna (author)
Uppsala universitet,Plattformen för preklinisk PET
Dunås, Finn (author)
Sandström, Mattias (author)
Uppsala universitet,Enheten för medicinsk strålfysik
Löfblom, John (author)
KTH,Proteinteknologi
Tolmachev, Vladimir (author)
Uppsala universitet,Enheten för biomedicinsk strålningsvetenskap
Ståhl, Stefan (author)
KTH,Proteinteknologi
show less...
 (creator_code:org_t)
Elsevier BV, 2014
2014
English.
In: European Journal of Medicinal Chemistry. - : Elsevier BV. - 0223-5234 .- 1768-3254. ; 87, s. 519-28
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Affibody molecules constitute a class of small (7 kDa) scaffold proteins that can be engineered to have excellent tumor targeting properties. High reabsorption in kidneys complicates development of affibody molecules for radionuclide therapy. In this study, we evaluated the influence of the composition of cysteine-containing C-terminal peptide-based chelators on the biodistribution and renal retention of (188)Re-labeled anti-HER2 affibody molecules. Biodistribution of affibody molecules containing GGXC or GXGC peptide chelators (where X is G, S, E or K) was compared with biodistribution of a parental affibody molecule ZHER2:2395 having a KVDC peptide chelator. All constructs retained low picomolar affinity to HER2-expressing cells after labeling. The biodistribution of all (188)Re-labeled affibody molecules was in general comparable, with the main observed difference found in the uptake and retention of radioactivity in excretory organs. The (188)Re-ZHER2:V2 affibody molecule with a GGGC chelator provided the lowest uptake in all organs and tissues. The renal retention of (188)Re-ZHER2:V2 (3.1 ± 0.5 %ID/g at 4 h after injection) was 55-fold lower than retention of the parental (188)Re-ZHER2:2395 (172 ± 32 %ID/g). We show that engineering of cysteine-containing peptide-based chelators can be used for significant improvement of biodistribution of (188)Re-labeled scaffold proteins, particularly reduction of their uptake in excretory organs.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Annan medicin och hälsovetenskap -- Övrig annan medicin och hälsovetenskap (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Other Medical and Health Sciences -- Other Medical and Health Sciences not elsewhere specified (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology (hsv//eng)

Keyword

Affibody
Affinity discrimination
Cell surface display
FACS
Gram positive
Staphylococcus carnosus
immunoglobulin G
membrane protein
antibody combining site
article
binding affinity
cell interaction
cellular distribution
evaluation
fluorescence activated cell sorting
nonhuman
priority journal
protein domain
protein expression
protein localization
protein targeting
signal transduction
Staphylococcus
Staphylococcus carnosus
surface property
Amino Acid Sequence
Antibody Affinity
Flow Cytometry
Immunoglobulin G
Molecular Sequence Data
Mutation
Peptide Library
Protein Structure
Tertiary
Recombinant Proteins
Sequence Alignment
Staphylococcal Protein A
Staphylococcus
Transformation
Bacterial
Posibacteria
Staphylococcus carnosus

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view